Contact - VaxNewMo

News & Press
Platform
- Vaccines
Team
Contact
Careers

News & Press
Platform
- Vaccines
Team
Contact
Careers

colorArtboard 4AFC-COLOR

Contact Us

| 4340 Duncan Ave, Suite 202 St. Louis, MO 63110
| info@vaxnewmo.com

About our company

VaxNewMo
an early stage biotechnological company developing next-generation conjugate vaccines against infectious diseases using our proprietary in vivo conjugating technology.

Address: 4340 Duncan, Suite 202
St. Louis, MO 63110
Email: info@vaxnewmo.com
© Copyright VaxNewMo

Recent Media

VaxNewMo developing a vaccine for one of the world’s deadliest microbes
VaxNewMo publishes its platform technology manuscript in Nature Communications
How one St. Louis biotech startup is proving it’s the real deal
Check out our latest review article on glycoengineering coli for bioconjugate vaccine, therapeutic and diagnostic production
VaxNewMo’s Vaccine Breakthrough Published In Nature

Newsletter

Your Email (required)

Important Links